DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20194799

Analysis of spontaneous individual case safety reports reported at adverse drug reaction monitoring centre: tertiary care teaching hospital in South India

E. Bhuvaneshwari, T. Chakradhar, M. Sravani

Abstract


Background: Drugs are double edged weapons, they are used in treatment of the patients but in return can harm as well. The safety of drug prescribing has become a need of the hour topic in medicine. Safety monitoring of patients via Pharmacovigilance tool has become an integral part of pharmacotherapy. This study has been undertaken to analyze the various individual case safety reports including the Special situation cases of medicational error and over dose and to promote the reporting of adverse drug reactions (ADRs) among the healthcare professionals (HCPs).

Methods: A retrospective non-interventional observational study was done for indexed period of six months at AMC-PvPI under Osmania Medical College and General Hospital. The reported individual case safety reports (ICSRs) are evaluated on basis of demographics of age and gender, seriousness criteria, outcome parameters and causality assessment of suspected drug (s) and suspected ADR/AE (s) as per the ICH guidelines and WHO causality assessment scale.

Results: A total of 177 ICSRs are reported out of that 137 were ADRs, 36-medication error cases and 4-cases of over dose. The incidence of ADRs in females are high compared with males was identical. The occurrence of ADRs in adult patients (61%) was significantly higher than other age groups. Of total ADRs, most of them were with analgesics (26%) and highly reported system organ classification was CNS. Overall, 79% patients were recovered from ADRs.

Conclusions: The results depicted an insight to the HCPs on the importance of monitoring and reporting of ICSRs. Our study results emphasized need to roll out a pharmacovigilance practice tool to ensure the safe use of drugs for better Pharmacotherapy and development of pharmacogenomic studies.


Keywords


Health care professionals, Individual Case safety report, System organ classification, Adverse drug reaction, Adverse event, Toxic epidermal necrolysis

Full Text:

PDF

References


India Population. Available at: http://worldpopulation review.com/countries/india/. Accessed on 12 August 2019.

Shamna M, Dilip C, Ajmal M, Mohan ML, Shinu C, Jafer CP, et al. A prospective study on Adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceutical J. 2014;22(4):303-8.

Adhikari A, Bhattacharjee N, Bhattacharya S, Indu R, Ray M. Evaluation of adverse drug reports from a tertiary care hospital of Kolkata, West Bengal, India. J Young Pharm. 2017;9(3):311-4.

Sharma HL, Sharma KK. General Principles of Pharmacology. Principles of Pharmacology. 2nd ed. New Delhi: Paras Medical Publishers; 2011: 1-2.

Venkatasubbaiah MP, Reddy D, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alexandria J Med. 2018;54(4):597-603.

Safety of Medicines In Public Health Programmes: Pharmacovigilance an essential tool, World Health Organization 2006. Available at: https://www.Who .int/medicines/areas/quality_safety/safety_efficacy/ Pharmacovigilance_B.pdf?ua=1. Accessed on 8 August 2019.

Sneha G, Sowmya N, Goka P, Rao N, Prasanthi N, Nadendia R, et al. An observational prospective study on prevalence and monitoring of adverse drug reactions in tertiary care teaching hospital. BJPR. 2016;11:1-9.

Kalaiselvan V, Thota P, Singh GN. Pharmacovigilance programme of India: recent developments and future perspectives. Ind J Pharmacol. 2016;48:624-8.

Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India. List of Adverse Drug Reaction monitoring Centers under PvPI. Available at: https://www.ipc.gov.in/ images/LIST_OF_270_AMC_UNDER_PvPI.pdf. Accessed on 8 August 2019.

Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India. ADR reporting form for HCPs. Available at: https://www.ipc.gov.in/PvPI/adr/ADR%20Reporting%20Form.pdf. Accessed on 21 August 2019.

Pharmacovigilance Program of India. Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India. Consumer reporting Medicines side effects reporting form in vernacular language Available at: https://www.ipc .gov.in/PvPI/adr/Telugu.pdf. Accessed on 21 August 2019.

Rajan A, Ramani PT, Raj S. A study on pattern of adverse drug reaction in an adverse drug reaction monitoring centre of a tertiary care hospital in South Kerala. Int J Basic Clin Pharmacol. 2019;8(8):1813-8.

Ferner RE. Adverse drug reactions. Medicine. 2016;44(7):416-21.

Alshakka M, Saeed GMA, Ali H, Prajapati SK, Ibrahim MI. Adverse Drug reactions and medication errors in tertiary care hospitals: a quantitative insight in Aden, Yemen. J Young Pharm. 2019;11(1):82-7.

World Health Organization. The third WHO Global Patient Safety Challenge: medication without harm. Available at: https://www.who.int/patientsafety/medi cation-safety/en/. Accessed on 21 August 2019.

Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services. Patient safety network. Medication Errors and Adverse Drug Events. Available at: https://psnet.ahrq.gov/primers/primer/23/Medication-Errors-and-Adverse-Drug-Events. Accessed on 21 August 2019.

Petrova G, Stoimenova A, Dimitrova M, Kamusheva M, Petrova D, Georgiev O. Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy. Sage Open Med J. 2017;5(1):7.

Singh H, Dulhani N, Kumar BN, Singh P, Tewari P, Nayak K. A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh (Jagdalpur), India. J Young Pharm. 2010;2(1):95-100.

Gaur S, Paramjeet S, Srivastava B, Bhardwaj R, Ahuja S, Gunjita B. Evaluation of adverse drug reactions in teaching hospital in Kumoun region. JMSCR. 2016;4:12139-45.

Tabassum N, MohdIlyas, Ghori S, Reddy A, Mohiuddin M. Dermatological Adverse drug reactions in tertiary care hospital. Int J Pharm Sci Res. 2015;6(2):816-24.

Vijayakumar TM, Dhanaraju MD. Description of adverse drug reactions in a multi-specialty teaching hospital. Int J Integr Med. 2013;1:1-6.

Kathiria JM, Sattigeri BM, Desai PM, Patel SP. A Study of adverse drug reactions in patients admitted to intensive care unit of a tertiary care teaching rural hospital. Int J Pharm Pharm Sci. 2013;5(1):160-315.

Lobo GMA, Pinheiro SMB, Castro JGD, Momente VG, Pranchevicius MCS. Adverse drug reaction monitoring: support for Pharmacovigilance at a tertiary care hospital in northern Brazil. BMC Pharmacol Toxicol. 2013;14:5.

Swamy S, Bhanuprakash NP, Muralimohan SM. Profile of suspect adverse drug reactions in a teaching tertiary care hospital. J Pharmacol Clin Toxicol. 2013;1(1):1005.

Sen M, Singh A, Misra M. Retrospective analysis of adverse drug reactions reported at ADR monitoring centre under PvPI in a tertiary care hospital. Int J Basic Clin Pharmacol. 2018;7(7):303-8.

Mishra R, Jeevangi SK, Vardhamane S, Kumar S. Pharmacovigilance study in medicine department in a tertiary care hospital. Int J Basic Clin Pharmacol. 2016;5:2608-15.

Hemavathy G, Rathinam J, Preethi A, Divakar R. A retrospective analysis of adverse drug reactions reported at a tertiary care hospital in South India. Int J Basic Clin Pharmacol. 2018;7:1257-62.

Badyal DK, Kanish B, Gulrez G. Causality assessment and pattern of adverse drug reactions in a tertiary care hospital. Int J Basic Clin Pharmacol. 2018;7:210-4.

Sood A, Sood V, Prajapati H, Sharma A, Bansal R, Mahajan V. Pharmacovigilance analysis in a rural tertiary care hospital in North India: a retrospective study. Int J Basic Clin Pharmacol. 2016;5:1425-31.

Chan SL, Ang X, Sani LL, Ng HY, Winther MD, Liu JJ, et al. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Bri J Clin Pharmac. 2016;82(6):1636-46.